Current findings for recurring mutations in acute myeloid leukemia
about
The epigenetic landscape of acute myeloid leukemiaMyeloid malignancies: mutations, models and management'Acute myeloid leukemia: a comprehensive review and 2016 update'Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysisClinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome.Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse.The HARE-HTH and associated domains: novel modules in the coordination of epigenetic DNA and protein modificationsSU11652 Inhibits tyrosine kinase activity of FLT3 and growth of MV-4-11 cellsFbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.Identification of an orally available compound with potent and broad FLT3 inhibition activityMolecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patientsUsing bioinformatic approaches to identify pathways targeted by human leukemogensClinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patientsGeneration and characterization of a highly effective protein substrate for analysis of FLT3 activityThe role of A20 in the pathogenesis of lymphocytic malignancy.The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia.Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML.Recent advances and novel agents for FLT3 mutated acute myeloid leukemia.Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcomeTargeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia.Molecular functions of metallothionein and its role in hematological malignancies.DNMT3A: the DioNysian MonsTer of acute myeloid leukaemia.Selective inhibitors of nuclear export (SINE) in hematological malignancies.ETV6/ARG oncoprotein confers autonomous cell growth by enhancing c-Myc expression via signal transducer and activator of transcription 5 activation in the acute promyelocytic leukemia cell line HT93A.Prediction of the number of activated genes in multiple independent Cd(+2)- and As(+3)-induced malignant transformations of human urothelial cells (UROtsa).The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China.RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia.Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation statusThe corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia.CBL RING finger deletions are common in core-binding factor acute myeloid leukemias.Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis.FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.Prevalence and Clinical Significance of FLT3 and NPM1 Mutations in Acute Myeloid Leukaemia Patients of Assam, India.Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia.Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutation.
P2860
Q21284742-C66E672A-715B-4264-9B1F-2F9681C7FE0CQ27000577-042F17C5-BCA2-4BEB-BD70-0D6200B926BDQ28072539-9AC2699A-CF41-42FC-A62D-058E41BDA647Q33404677-B31D38D9-3688-4D75-9932-E80D765D2D89Q33572303-E4DDAF7D-82B0-492C-97D2-0E244219B0ECQ33641201-53EF939E-4EBF-4EF5-804D-7268C2EFD2C4Q34086334-B00FE5F6-35BD-4763-96BA-9858912FCD96Q34107107-375D1DCA-9221-4061-A4E4-4D816D56FF24Q34502608-C78B39D9-1F9F-432A-93C0-F6B980616331Q35661995-B69284FE-5785-4843-9BCA-BE7058F658E2Q35789739-EAA6FD8D-3D90-45F8-B877-2B8E147AA608Q35873466-37E9CCAC-2520-4044-9EDC-8F6FB56C1DF1Q36126146-1CBF74CD-04D5-4446-B306-D184B364270FQ36162589-E9CF3D7A-D5FD-44CD-B9BD-128C57F1901CQ36165726-7B102E60-0FF3-42CF-95D4-1A023CB5C2DAQ36455774-53F9E3B6-309D-4B92-8E05-B0EDDCAB0BBFQ36513656-256D183E-C864-4276-82A6-A79D2268C3C9Q36811519-F64CA32F-7F93-46DD-BAC3-3F48DBC5EFB1Q37043763-66536C93-6244-451B-A999-3EF9DDC0CCB4Q37220129-8CCD5F07-91FC-4CC4-9BEF-6D0999924D4CQ37327786-97500D1D-F619-4796-AC48-09A6189A4BDDQ38011962-2B625E5E-A69E-462E-BED4-A98773E370B4Q38030059-22E0C725-B9F7-4FD9-9839-D3057D597D84Q38282093-5E92E1DF-6B37-4E40-BB6C-961890579F74Q38368605-8D5BBEA1-8B58-493D-9593-A1BC20EA9AA8Q38942449-B19DB5BE-AE67-4348-B746-638E8FE2B79BQ39030350-2AFBCEB0-B2BF-4556-8938-60B5A857E9C6Q40202671-F92288CD-B8D2-4072-9619-9A1CAD5CF88DQ41545370-7E4C3512-53BE-476A-BBA2-2D6A73980B91Q41573002-CE1CF3F8-5ED0-480C-8F44-F99170B665D5Q41908916-D8E82966-D185-4CE7-96CC-6DC10FA356DAQ43043026-7AABE2EE-4D2E-4248-828B-A564504FB133Q44076785-922A2D55-B0D2-42C9-8B5B-ADCFE9D549B9Q45876973-7E7B38B4-806E-43CD-93D1-6291EBA3384EQ47558620-C90F7024-AD53-4503-A576-146D0568CB91Q49181559-23205A70-68CC-4C1E-9862-10D14A99F011Q49338358-4F5B8097-ECD3-495B-8907-42DF6828883FQ51134421-DCA4F62A-60DD-476D-86A0-E719A96F5E41Q55059516-DCD54788-9410-4D2C-8025-F5F07B3F68B2
P2860
Current findings for recurring mutations in acute myeloid leukemia
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current findings for recurring mutations in acute myeloid leukemia
@en
Current findings for recurring mutations in acute myeloid leukemia.
@nl
type
label
Current findings for recurring mutations in acute myeloid leukemia
@en
Current findings for recurring mutations in acute myeloid leukemia.
@nl
prefLabel
Current findings for recurring mutations in acute myeloid leukemia
@en
Current findings for recurring mutations in acute myeloid leukemia.
@nl
P2860
P356
P1476
Current findings for recurring mutations in acute myeloid leukemia
@en
P2093
Shinichiro Takahashi
P2860
P2888
P356
10.1186/1756-8722-4-36
P5008
P577
2011-09-14T00:00:00Z
P5875
P6179
1050289405